Measuring the economic benefit of treatment with atypical antipsychotics
Please note: this is a legacy publication from CPEC (formely PSSRU at LSE).European Psychiatry 13 supplement 1 37-45
Abstract
Schizophrenia has a major impact on the quality of life of sufferers, and its broader impact on families and on society are well known, although less thoroughly documented. The majority of sufferers require long-term treatment and support, and there ar